MOS
42
3
APA
25
5
NOC
34
-6
IBM
50
-3
TGNA
56
-3
BXP
52
2
RIG
50
6
CHD
50
2
ADP
68
-4
EA
67
2
JBHT
60
-3
DGX
39
-9
MUR
48
3
KIM
70
-3
AMAT
46
3
LEG
37
6
FE
41
-3
URBN
55
-11
CVS
47
2
EXPD
48
5
MOS
42
3
APA
25
5
NOC
34
-6
IBM
50
-3
TGNA
56
-3
BXP
52
2
RIG
50
6
CHD
50
2
ADP
68
-4
EA
67
2
JBHT
60
-3
DGX
39
-9
MUR
48
3
KIM
70
-3
AMAT
46
3
LEG
37
6
FE
41
-3
URBN
55
-11
CVS
47
2
EXPD
48
5
Financhill
Back

ProShares Ultra MSCI Brazil Capped Vs. Dyne Therapeutics Industry Stock Comparison

Sell
38

UBR
ProShares Ultra MSCI Brazil Capped

Last Price:
19.96
Seasonality Move:
2.6%
Sell
46

DYN
Dyne Therapeutics

Last Price:
30.40
Seasonality Move:
38.02%
Sell
38
ProShares Ultra MSCI Brazil Capped (UBR) is a Sell

Is ProShares Ultra MSCI Brazil Capped a Buy, Sell or Hold?

  • The current ProShares Ultra MSCI Brazil Capped [UBR] share price is $19.52. The Score for UBR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • UBR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Dyne Therapeutics (DYN) is a Sell

Is Dyne Therapeutics a Buy, Sell or Hold?

  • The current Dyne Therapeutics [DYN] share price is $30.31. The Score for DYN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • DYN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

UBR Stock Price Chart

What is ProShares Ultra MSCI Brazil Capped's stock price today?

  • The ProShares Ultra MSCI Brazil Capped share price today is $19.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UBR is experiencing buying pressure, which is a positive indicator for future bullish movement.

DYN Stock Price Chart

What is Dyne Therapeutics's stock price today?

  • The Dyne Therapeutics share price today is $30.31
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing selling pressure, which indicates risk of future bearish movement.

UBR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.51 Sell
Relative Strength Index (14 RSI): 38.07 Sell
Chaikin Money Flow: 1556 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.94 - 21.16) Sell
Bollinger Bands (100): (20.52 - 23.8) Sell

DYN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.91 Sell
Relative Strength Index (14 RSI): 47.11 Sell
Chaikin Money Flow: -1019710 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.92 - 33.44) Sell
Bollinger Bands (100): (31.39 - 42.57) Sell

UBR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.22 Sell
20-day SMA: 20.38 Sell
50-day SMA: 21.76 Sell
200-day SMA: 24.45 Sell
8-day EMA: 20.04 Sell
20-day EMA: 20.47 Sell
50-day EMA: 21.38 Sell
200-day EMA: 23.75 Sell

DYN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.77 Buy
20-day SMA: 30.55 Sell
50-day SMA: 32.55 Sell
200-day SMA: 32.11 Sell
8-day EMA: 30.26 Buy
20-day EMA: 30.69 Sell
50-day EMA: 32.85 Sell
200-day EMA: 30.82 Sell

ProShares Ultra MSCI Brazil Capped Earnings Growth & UBR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Dyne Therapeutics Earnings Growth & DYN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.10 per share.

ProShares Ultra MSCI Brazil Capped Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Dyne Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):